3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Gastrointestinal
44
Breast
30
Thoracic
27
Gynecologic
10
Head & Neck
9
Lymphoid
7
Genitourinary
7
Sarcoma
6
Other hematologic neoplasm
6
Dermatologic
4
CNS
4
Tumor-Agnostic
3
Plasma cell
3
Other solid neoplasm
2
NET
2
Myeloid
2
Endocrine
2
Other
1
Classical hematology
1
Conditions
Sexual Dysfunction, Physiological
1
Lung Neoplasms
1
Interventions
Surveys and Questionnaires
9
Blood Specimen Collection
5
naloxegol
3
Therapeutics
3
Observation
3
Interviews as Topic
3
Bariatric Surgery
3
naldemedine
2
exemestane
2
Tirzepatide
2
Tamoxifen
2
Psychiatric Rehabilitation
2
Paclitaxel
2
Hematologic Tests
2
Esophagectomy
2
Echocardiography
2
Carboplatin
2
Biopsy
2
BaseLine dental cement
2
Anastrozole
2
trametinib
1
sotorasib
1
semaglutide
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Drug Therapy
×
Other
×
Clear all
NCT06018376
2026-02-06
LUDICAS
Fundación GECP
Completed
553 enrolled
6 charts